70 related articles for article (PubMed ID: 22985603)
1. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets.
Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
Int J Pharm; 2012 Nov; 438(1-2):296-301. PubMed ID: 22985603
[TBL] [Abstract][Full Text] [Related]
2. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
3. Decoration of fibrinogen γ-chain peptide on adenosine diphosphate-encapsulated liposomes enhances binding of the liposomes to activated platelets.
Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
Int J Pharm; 2011 Apr; 407(1-2):151-7. PubMed ID: 21251962
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
Suzuki H; Okamura Y; Ikeda Y; Takeoka S; Handa M
Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
Okamura Y; Maekawa I; Teramura Y; Maruyama H; Handa M; Ikeda Y; Takeoka S
Bioconjug Chem; 2005; 16(6):1589-96. PubMed ID: 16287259
[TBL] [Abstract][Full Text] [Related]
6. Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.
Okamura Y; Fukui Y; Kabata K; Suzuki H; Handa M; Ikeda Y; Takeoka S
Bioconjug Chem; 2009 Oct; 20(10):1958-65. PubMed ID: 19788180
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of the structural components of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
Taguchi K; Ujihira H; Ogaki S; Watanabe H; Fujiyama A; Doi M; Okamura Y; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
Drug Metab Dispos; 2013 Aug; 41(8):1584-91. PubMed ID: 23735758
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
Okamura Y; Takeoka S; Teramura Y; Maruyama H; Tsuchida E; Handa M; Ikeda Y
Transfusion; 2005 Jul; 45(7):1221-8. PubMed ID: 15987370
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Nishikawa K; Hagisawa K; Kinoshita M; Shono S; Katsuno S; Doi M; Yanagawa R; Suzuki H; Iwaya K; Saitoh D; Sakamoto T; Seki S; Takeoka S; Handa M
J Thromb Haemost; 2012 Oct; 10(10):2137-48. PubMed ID: 22905905
[TBL] [Abstract][Full Text] [Related]
10. Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute.
Okamura Y; Katsuno S; Suzuki H; Maruyama H; Handa M; Ikeda Y; Takeoka S
J Control Release; 2010 Dec; 148(3):373-9. PubMed ID: 20875473
[TBL] [Abstract][Full Text] [Related]
11. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
12. New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.
Okamura Y; Handa M; Suzuki H; Ikeda Y; Takeoka S
J Artif Organs; 2006; 9(4):251-8. PubMed ID: 17171404
[TBL] [Abstract][Full Text] [Related]
13. Function of fibrinogen gamma-chain dodecapeptide-conjugated latex beads under flow.
Takeoka S; Okamura Y; Teramura Y; Watanabe N; Suzuki H; Tsuchida E; Handa M; Ikeda Y
Biochem Biophys Res Commun; 2003 Dec; 312(3):773-9. PubMed ID: 14680832
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-platelet peptide (Z4A5) potential for glycoprotein IIb/IIIa inhibits platelet aggregation.
Li YX; Sun Q; Zhang H; Ren ST; Liao YR; Wang Y; Shen XL; Wang B
Thromb Res; 2012 May; 129(5):e217-22. PubMed ID: 22445430
[TBL] [Abstract][Full Text] [Related]
15. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
16. The AGDV residues on the gamma chain carboxyl terminus of platelet-bound fibrinogen are needed for platelet aggregation.
Liu Q; Matsueda G; Brown E; Frojmovic M
Biochim Biophys Acta; 1997 Dec; 1343(2):316-26. PubMed ID: 9434121
[TBL] [Abstract][Full Text] [Related]
17. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute in an anticancer drug-induced thrombocytopenia rat model.
Taguchi K; Ujihira H; Watanabe H; Fujiyama A; Doi M; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
J Pharm Sci; 2013 Oct; 102(10):3852-9. PubMed ID: 23918456
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
Wittig K; Rothe G; Schmitz G
Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053
[TBL] [Abstract][Full Text] [Related]
20. Interactions of platelets with Synthocytes, a novel platelet substitute.
Davies AR; Judge HM; May JA; Glenn JR; Heptinstall S
Platelets; 2002 Jun; 13(4):197-205. PubMed ID: 12189020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
